Analysis of Risk Factors of Coagulation Dysfunction and Hemorrhage in Newly Diagnosed Hyperleukocytic Acute Myeloma Leukemia

Table 2

Abnormal rates of coagulation indexes and hemorrhage rates in 76 patients with hyperleukocytic.

Abnormal items of coagulation index	n	Level 0 hemorrhage	Level 1 hemorrhage	Level 2 hemorrhage
0 items	6	6 (100%)	0 (0%)	0 (0%)
1 item	15	5 (33.3%)	6 (40%)	4 (26.7%)
2 items	22	3 (13.6%)	10 (45.5%)	9 (40.9%)
≥3 items	33	6 (18.2%)	10 (30.3%)	17 (51.5%)

Level 0: no symptoms of bleeding; Level 1: there are skin bleeding points, mild gingival or nasal bleeding, positive erythrocyte by uroscopy, positive occult fecal blood; Level 2: large skin ecchymosis and bleeding at the injection site, nonstop bleeding from gums and/or nose, gross hematuria, black stool, fundus hemorrhage, intracranial hemorrhage. Compared with 0 abnormalities, ; compared with 0 items, .